![Michael Bolinder](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
Michael Bolinder worked at Mallinckrodt Pharmaceuticals Ltd. from 2013 to 2015 as Head-Marketing & Commercial Strategy.
From 2015 to 2022, Mr. Bolinder was at Acacia Pharma Group Ltd., serving as Chief Executive Officer from 2019 to 2022.
Mr. Bolinder completed undergraduate education at Florida State University.
Precedenti posizioni note di Michael Bolinder
| Società | Posizione | Fine |
|---|---|---|
| ACACIA PHARMA GROUP PLC | Amministratore Delegato | 01/06/2022 |
Mallinckrodt Pharmaceuticals Ltd.
 Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Vendite & Marketing | 01/08/2015 |
Formazione di Michael Bolinder
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
7
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Florida State University
 Florida State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acacia Pharma Group Ltd.
 Acacia Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company that engages in developing and commercializing novel products for surgery, invasive procedures & chemotherapy | Health Technology |
Mallinckrodt Pharmaceuticals Ltd.
Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
